Christopher Chapman
2020
In 2020, Christopher Chapman earned a total compensation of $297.5K as President, Chief Medical Officer at Akers Biosciences.
Compensation breakdown
| Option Awards | $270,000 |
|---|---|
| Salary | $27,500 |
| Total | $297,500 |
Chapman received $270K in option awards, accounting for 91% of the total pay in 2020.
Chapman also received $27.5K in salary.
Rankings
In 2020, Christopher Chapman's compensation ranked 12,142nd out of 13,090 executives tracked by ExecPay. In other words, Chapman earned more than 7.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,142 out of 13,090 | 7th |
Division Manufacturing | 5,197 out of 5,621 | 8th |
Major group Chemicals And Allied Products | 2,112 out of 2,254 | 6th |
Industry group Drugs | 1,838 out of 1,954 | 6th |
Industry In Vitro and In Vivo Diagnostic Substances | 55 out of 60 | 8th |
Source: SEC filing on October 26, 2022.
Chapman's colleagues
We found four more compensation records of executives who worked with Christopher Chapman at Akers Biosciences in 2020.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021